Yahoo
OTC Markets OTCPK - Delayed Quote USD

Braxia Scientific Corp. (BRAXF)

0.0001 0.0000 (0.00%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for BRAXF
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0010 x --
  • Ask 0.0015 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0013
  • Volume 480,000
  • Avg. Volume 39
  • Market Cap (intraday) 28,328
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Mississauga, Canada.

braxiascientific.com

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

BRAXF
0.00%
S&P/TSX Composite index (^GSPTSE)
12.94%

1-Year Return

BRAXF
92.19%
S&P/TSX Composite index (^GSPTSE)
18.93%

3-Year Return

BRAXF
98.79%
S&P/TSX Composite index (^GSPTSE)
83.38%

5-Year Return

BRAXF
99.93%
S&P/TSX Composite index (^GSPTSE)
70.01%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -42.36%

  • Return on Equity (ttm)

    -254.59%

  • Revenue (ttm)

    2.21M

  • Net Income Avi to Common (ttm)

    -9.64M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    128.34k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -970.83k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: